Annual Working Capital
$21.76 M
-$38.10 M-63.64%
31 December 2023
Summary:
Finch Therapeutics annual working capital is currently $21.76 million, with the most recent change of -$38.10 million (-63.64%) on 31 December 2023. During the last 3 years, it has fallen by -$72.92 million (-77.01%). FNCH annual working capital is now -82.97% below its all-time high of $127.76 million, reached on 31 December 2021.FNCH Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$12.82 M
-$4.86 M-27.49%
30 June 2024
Summary:
Finch Therapeutics quarterly working capital is currently $12.82 million, with the most recent change of -$4.86 million (-27.49%) on 30 June 2024. Over the past year, it has dropped by -$12.22 million (-48.81%). FNCH quarterly working capital is now -93.14% below its all-time high of $186.84 million, reached on 31 March 2021.FNCH Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FNCH Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -63.6% | -48.8% |
| 3 y3 years | -77.0% | -91.3% |
| 5 y5 years | - | - |
FNCH Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -83.0% | at low | -91.3% | at low |
| 5 y | 5 years | -83.0% | at low | -93.1% | at low |
| alltime | all time | -83.0% | at low | -93.1% | at low |
Finch Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $12.82 M(-27.5%) |
| Mar 2024 | - | $17.68 M(-18.8%) |
| Dec 2023 | $21.76 M(-63.6%) | $21.76 M(-13.1%) |
| Sept 2023 | - | $25.04 M(-7.0%) |
| June 2023 | - | $26.92 M(-10.8%) |
| Mar 2023 | - | $30.19 M(-49.6%) |
| Dec 2022 | $59.86 M | $59.86 M(-22.1%) |
| Sept 2022 | - | $76.81 M(-19.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $95.36 M(-9.9%) |
| Mar 2022 | - | $105.86 M(-17.1%) |
| Dec 2021 | $127.76 M(+34.9%) | $127.76 M(-13.3%) |
| Sept 2021 | - | $147.32 M(-12.0%) |
| June 2021 | - | $167.48 M(-10.4%) |
| Mar 2021 | - | $186.84 M(+97.3%) |
| Dec 2020 | $94.68 M(+129.2%) | $94.68 M |
| Dec 2019 | $41.30 M | - |
FAQ
- What is Finch Therapeutics annual working capital?
- What is the all time high annual working capital for Finch Therapeutics?
- What is Finch Therapeutics annual working capital year-on-year change?
- What is Finch Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Finch Therapeutics?
- What is Finch Therapeutics quarterly working capital year-on-year change?
What is Finch Therapeutics annual working capital?
The current annual working capital of FNCH is $21.76 M
What is the all time high annual working capital for Finch Therapeutics?
Finch Therapeutics all-time high annual working capital is $127.76 M
What is Finch Therapeutics annual working capital year-on-year change?
Over the past year, FNCH annual working capital has changed by -$38.10 M (-63.64%)
What is Finch Therapeutics quarterly working capital?
The current quarterly working capital of FNCH is $12.82 M
What is the all time high quarterly working capital for Finch Therapeutics?
Finch Therapeutics all-time high quarterly working capital is $186.84 M
What is Finch Therapeutics quarterly working capital year-on-year change?
Over the past year, FNCH quarterly working capital has changed by -$12.22 M (-48.81%)